Veterinary Analgesics and Anti-Inflammatory Market Size & Share by 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Veterinary Analgesics and Anti-Inflammatory Market Size Analysis

Global Veterinary Analgesics and Anti-Inflammatory Market Introduction
By Drug Class
1. Introduction
  1. Drug Class By Value
2. Non-steroidal anti-inflammatory drugs (NSAIDs)
  1. By Value
3. Opioids and partial agonists
  1. By Value
4. Local anaesthetics/nerve blocks
  1. By Value
5. Corticosteroids
  1. By Value
6. Biologics / monoclonal antibodies
  1. By Value
7. Adjunctive analgesics
  1. By Value
8. Topical analgesics/counterirritants
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral solids
  1. By Value
3. Oral liquids
  1. By Value
4. Injectable
  1. By Value
5. Transdermal/topical
  1. By Value
6. Implantable / depot formulations
  1. By Value
7. Ophthalmic/local formulations
  1. By Value
By Animal Class
1. Introduction
  1. Animal Class By Value
2. Companion animals
  1. By Value
3. Equine
  1. By Value
4. Production/food animals
  1. By Value
5. Laboratory/research animals
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Postoperative/perioperative pain control
  1. By Value
3. Chronic musculoskeletal pain
  1. By Value
4. Acute trauma/injury
  1. By Value
5. Procedural analgesia
  1. By Value
6. Topical/localised pain
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Veterinary hospitals and clinics
  1. By Value
3. Veterinary retail pharmacies and wholesalers
  1. By Value
4. Online pharmacies
  1. By Value
5. Farm supply/dealer channels
  1. By Value

North America Market Analysis

Introduction
By Drug Class
1. Introduction
  1. Drug Class By Value
2. Non-steroidal anti-inflammatory drugs (NSAIDs)
  1. By Value
3. Opioids and partial agonists
  1. By Value
4. Local anaesthetics/nerve blocks
  1. By Value
5. Corticosteroids
  1. By Value
6. Biologics / monoclonal antibodies
  1. By Value
7. Adjunctive analgesics
  1. By Value
8. Topical analgesics/counterirritants
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral solids
  1. By Value
3. Oral liquids
  1. By Value
4. Injectable
  1. By Value
5. Transdermal/topical
  1. By Value
6. Implantable / depot formulations
  1. By Value
7. Ophthalmic/local formulations
  1. By Value
By Animal Class
1. Introduction
  1. Animal Class By Value
2. Companion animals
  1. By Value
3. Equine
  1. By Value
4. Production/food animals
  1. By Value
5. Laboratory/research animals
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Postoperative/perioperative pain control
  1. By Value
3. Chronic musculoskeletal pain
  1. By Value
4. Acute trauma/injury
  1. By Value
5. Procedural analgesia
  1. By Value
6. Topical/localised pain
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Veterinary hospitals and clinics
  1. By Value
3. Veterinary retail pharmacies and wholesalers
  1. By Value
4. Online pharmacies
  1. By Value
5. Farm supply/dealer channels
  1. By Value
U.S.
1. By Drug Class
  1. Introduction
    1. Drug Class By Value
  2. Non-steroidal anti-inflammatory drugs (NSAIDs)
    1. By Value
  3. Opioids and partial agonists
    1. By Value
  4. Local anaesthetics/nerve blocks
    1. By Value
  5. Corticosteroids
    1. By Value
  6. Biologics / monoclonal antibodies
    1. By Value
  7. Adjunctive analgesics
    1. By Value
  8. Topical analgesics/counterirritants
    1. By Value
2. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral solids
    1. By Value
  3. Oral liquids
    1. By Value
  4. Injectable
    1. By Value
  5. Transdermal/topical
    1. By Value
  6. Implantable / depot formulations
    1. By Value
  7. Ophthalmic/local formulations
    1. By Value
3. By Animal Class
  1. Introduction
    1. Animal Class By Value
  2. Companion animals
    1. By Value
  3. Equine
    1. By Value
  4. Production/food animals
    1. By Value
  5. Laboratory/research animals
    1. By Value
4. By Indication
  1. Introduction
    1. Indication By Value
  2. Postoperative/perioperative pain control
    1. By Value
  3. Chronic musculoskeletal pain
    1. By Value
  4. Acute trauma/injury
    1. By Value
  5. Procedural analgesia
    1. By Value
  6. Topical/localised pain
    1. By Value
5. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Veterinary hospitals and clinics
    1. By Value
  3. Veterinary retail pharmacies and wholesalers
    1. By Value
  4. Online pharmacies
    1. By Value
  5. Farm supply/dealer channels
    1. By Value
Canada

Europe Market Analysis

Introduction
By Drug Class
1. Introduction
  1. Drug Class By Value
2. Non-steroidal anti-inflammatory drugs (NSAIDs)
  1. By Value
3. Opioids and partial agonists
  1. By Value
4. Local anaesthetics/nerve blocks
  1. By Value
5. Corticosteroids
  1. By Value
6. Biologics / monoclonal antibodies
  1. By Value
7. Adjunctive analgesics
  1. By Value
8. Topical analgesics/counterirritants
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral solids
  1. By Value
3. Oral liquids
  1. By Value
4. Injectable
  1. By Value
5. Transdermal/topical
  1. By Value
6. Implantable / depot formulations
  1. By Value
7. Ophthalmic/local formulations
  1. By Value
By Animal Class
1. Introduction
  1. Animal Class By Value
2. Companion animals
  1. By Value
3. Equine
  1. By Value
4. Production/food animals
  1. By Value
5. Laboratory/research animals
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Postoperative/perioperative pain control
  1. By Value
3. Chronic musculoskeletal pain
  1. By Value
4. Acute trauma/injury
  1. By Value
5. Procedural analgesia
  1. By Value
6. Topical/localised pain
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Veterinary hospitals and clinics
  1. By Value
3. Veterinary retail pharmacies and wholesalers
  1. By Value
4. Online pharmacies
  1. By Value
5. Farm supply/dealer channels
  1. By Value
U.K.
1. By Drug Class
  1. Introduction
    1. Drug Class By Value
  2. Non-steroidal anti-inflammatory drugs (NSAIDs)
    1. By Value
  3. Opioids and partial agonists
    1. By Value
  4. Local anaesthetics/nerve blocks
    1. By Value
  5. Corticosteroids
    1. By Value
  6. Biologics / monoclonal antibodies
    1. By Value
  7. Adjunctive analgesics
    1. By Value
  8. Topical analgesics/counterirritants
    1. By Value
2. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral solids
    1. By Value
  3. Oral liquids
    1. By Value
  4. Injectable
    1. By Value
  5. Transdermal/topical
    1. By Value
  6. Implantable / depot formulations
    1. By Value
  7. Ophthalmic/local formulations
    1. By Value
3. By Animal Class
  1. Introduction
    1. Animal Class By Value
  2. Companion animals
    1. By Value
  3. Equine
    1. By Value
  4. Production/food animals
    1. By Value
  5. Laboratory/research animals
    1. By Value
4. By Indication
  1. Introduction
    1. Indication By Value
  2. Postoperative/perioperative pain control
    1. By Value
  3. Chronic musculoskeletal pain
    1. By Value
  4. Acute trauma/injury
    1. By Value
  5. Procedural analgesia
    1. By Value
  6. Topical/localised pain
    1. By Value
5. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Veterinary hospitals and clinics
    1. By Value
  3. Veterinary retail pharmacies and wholesalers
    1. By Value
  4. Online pharmacies
    1. By Value
  5. Farm supply/dealer channels
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Drug Class
1. Introduction
  1. Drug Class By Value
2. Non-steroidal anti-inflammatory drugs (NSAIDs)
  1. By Value
3. Opioids and partial agonists
  1. By Value
4. Local anaesthetics/nerve blocks
  1. By Value
5. Corticosteroids
  1. By Value
6. Biologics / monoclonal antibodies
  1. By Value
7. Adjunctive analgesics
  1. By Value
8. Topical analgesics/counterirritants
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral solids
  1. By Value
3. Oral liquids
  1. By Value
4. Injectable
  1. By Value
5. Transdermal/topical
  1. By Value
6. Implantable / depot formulations
  1. By Value
7. Ophthalmic/local formulations
  1. By Value
By Animal Class
1. Introduction
  1. Animal Class By Value
2. Companion animals
  1. By Value
3. Equine
  1. By Value
4. Production/food animals
  1. By Value
5. Laboratory/research animals
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Postoperative/perioperative pain control
  1. By Value
3. Chronic musculoskeletal pain
  1. By Value
4. Acute trauma/injury
  1. By Value
5. Procedural analgesia
  1. By Value
6. Topical/localised pain
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Veterinary hospitals and clinics
  1. By Value
3. Veterinary retail pharmacies and wholesalers
  1. By Value
4. Online pharmacies
  1. By Value
5. Farm supply/dealer channels
  1. By Value
China
1. By Drug Class
  1. Introduction
    1. Drug Class By Value
  2. Non-steroidal anti-inflammatory drugs (NSAIDs)
    1. By Value
  3. Opioids and partial agonists
    1. By Value
  4. Local anaesthetics/nerve blocks
    1. By Value
  5. Corticosteroids
    1. By Value
  6. Biologics / monoclonal antibodies
    1. By Value
  7. Adjunctive analgesics
    1. By Value
  8. Topical analgesics/counterirritants
    1. By Value
2. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral solids
    1. By Value
  3. Oral liquids
    1. By Value
  4. Injectable
    1. By Value
  5. Transdermal/topical
    1. By Value
  6. Implantable / depot formulations
    1. By Value
  7. Ophthalmic/local formulations
    1. By Value
3. By Animal Class
  1. Introduction
    1. Animal Class By Value
  2. Companion animals
    1. By Value
  3. Equine
    1. By Value
  4. Production/food animals
    1. By Value
  5. Laboratory/research animals
    1. By Value
4. By Indication
  1. Introduction
    1. Indication By Value
  2. Postoperative/perioperative pain control
    1. By Value
  3. Chronic musculoskeletal pain
    1. By Value
  4. Acute trauma/injury
    1. By Value
  5. Procedural analgesia
    1. By Value
  6. Topical/localised pain
    1. By Value
5. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Veterinary hospitals and clinics
    1. By Value
  3. Veterinary retail pharmacies and wholesalers
    1. By Value
  4. Online pharmacies
    1. By Value
  5. Farm supply/dealer channels
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Drug Class
1. Introduction
  1. Drug Class By Value
2. Non-steroidal anti-inflammatory drugs (NSAIDs)
  1. By Value
3. Opioids and partial agonists
  1. By Value
4. Local anaesthetics/nerve blocks
  1. By Value
5. Corticosteroids
  1. By Value
6. Biologics / monoclonal antibodies
  1. By Value
7. Adjunctive analgesics
  1. By Value
8. Topical analgesics/counterirritants
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral solids
  1. By Value
3. Oral liquids
  1. By Value
4. Injectable
  1. By Value
5. Transdermal/topical
  1. By Value
6. Implantable / depot formulations
  1. By Value
7. Ophthalmic/local formulations
  1. By Value
By Animal Class
1. Introduction
  1. Animal Class By Value
2. Companion animals
  1. By Value
3. Equine
  1. By Value
4. Production/food animals
  1. By Value
5. Laboratory/research animals
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Postoperative/perioperative pain control
  1. By Value
3. Chronic musculoskeletal pain
  1. By Value
4. Acute trauma/injury
  1. By Value
5. Procedural analgesia
  1. By Value
6. Topical/localised pain
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Veterinary hospitals and clinics
  1. By Value
3. Veterinary retail pharmacies and wholesalers
  1. By Value
4. Online pharmacies
  1. By Value
5. Farm supply/dealer channels
  1. By Value
UAE
1. By Drug Class
  1. Introduction
    1. Drug Class By Value
  2. Non-steroidal anti-inflammatory drugs (NSAIDs)
    1. By Value
  3. Opioids and partial agonists
    1. By Value
  4. Local anaesthetics/nerve blocks
    1. By Value
  5. Corticosteroids
    1. By Value
  6. Biologics / monoclonal antibodies
    1. By Value
  7. Adjunctive analgesics
    1. By Value
  8. Topical analgesics/counterirritants
    1. By Value
2. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral solids
    1. By Value
  3. Oral liquids
    1. By Value
  4. Injectable
    1. By Value
  5. Transdermal/topical
    1. By Value
  6. Implantable / depot formulations
    1. By Value
  7. Ophthalmic/local formulations
    1. By Value
3. By Animal Class
  1. Introduction
    1. Animal Class By Value
  2. Companion animals
    1. By Value
  3. Equine
    1. By Value
  4. Production/food animals
    1. By Value
  5. Laboratory/research animals
    1. By Value
4. By Indication
  1. Introduction
    1. Indication By Value
  2. Postoperative/perioperative pain control
    1. By Value
  3. Chronic musculoskeletal pain
    1. By Value
  4. Acute trauma/injury
    1. By Value
  5. Procedural analgesia
    1. By Value
  6. Topical/localised pain
    1. By Value
5. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Veterinary hospitals and clinics
    1. By Value
  3. Veterinary retail pharmacies and wholesalers
    1. By Value
  4. Online pharmacies
    1. By Value
  5. Farm supply/dealer channels
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Drug Class
1. Introduction
  1. Drug Class By Value
2. Non-steroidal anti-inflammatory drugs (NSAIDs)
  1. By Value
3. Opioids and partial agonists
  1. By Value
4. Local anaesthetics/nerve blocks
  1. By Value
5. Corticosteroids
  1. By Value
6. Biologics / monoclonal antibodies
  1. By Value
7. Adjunctive analgesics
  1. By Value
8. Topical analgesics/counterirritants
  1. By Value
By Route of Administration
1. Introduction
  1. Route of Administration By Value
2. Oral solids
  1. By Value
3. Oral liquids
  1. By Value
4. Injectable
  1. By Value
5. Transdermal/topical
  1. By Value
6. Implantable / depot formulations
  1. By Value
7. Ophthalmic/local formulations
  1. By Value
By Animal Class
1. Introduction
  1. Animal Class By Value
2. Companion animals
  1. By Value
3. Equine
  1. By Value
4. Production/food animals
  1. By Value
5. Laboratory/research animals
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. Postoperative/perioperative pain control
  1. By Value
3. Chronic musculoskeletal pain
  1. By Value
4. Acute trauma/injury
  1. By Value
5. Procedural analgesia
  1. By Value
6. Topical/localised pain
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Veterinary hospitals and clinics
  1. By Value
3. Veterinary retail pharmacies and wholesalers
  1. By Value
4. Online pharmacies
  1. By Value
5. Farm supply/dealer channels
  1. By Value
Brazil
1. By Drug Class
  1. Introduction
    1. Drug Class By Value
  2. Non-steroidal anti-inflammatory drugs (NSAIDs)
    1. By Value
  3. Opioids and partial agonists
    1. By Value
  4. Local anaesthetics/nerve blocks
    1. By Value
  5. Corticosteroids
    1. By Value
  6. Biologics / monoclonal antibodies
    1. By Value
  7. Adjunctive analgesics
    1. By Value
  8. Topical analgesics/counterirritants
    1. By Value
2. By Route of Administration
  1. Introduction
    1. Route of Administration By Value
  2. Oral solids
    1. By Value
  3. Oral liquids
    1. By Value
  4. Injectable
    1. By Value
  5. Transdermal/topical
    1. By Value
  6. Implantable / depot formulations
    1. By Value
  7. Ophthalmic/local formulations
    1. By Value
3. By Animal Class
  1. Introduction
    1. Animal Class By Value
  2. Companion animals
    1. By Value
  3. Equine
    1. By Value
  4. Production/food animals
    1. By Value
  5. Laboratory/research animals
    1. By Value
4. By Indication
  1. Introduction
    1. Indication By Value
  2. Postoperative/perioperative pain control
    1. By Value
  3. Chronic musculoskeletal pain
    1. By Value
  4. Acute trauma/injury
    1. By Value
  5. Procedural analgesia
    1. By Value
  6. Topical/localised pain
    1. By Value
5. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Veterinary hospitals and clinics
    1. By Value
  3. Veterinary retail pharmacies and wholesalers
    1. By Value
  4. Online pharmacies
    1. By Value
  5. Farm supply/dealer channels
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Veterinary Analgesics and Anti-Inflammatory Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Zoetis
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Elanco
Merck Animal Health (MSD)
Boehringer Ingelheim Animal Health
Dechra
Ceva Santé Animale
Vetoquinol
Virbac
Bayer Animal Health
Norbrook
Phibro
Hipra
Ceva
Bayer/Elanco
Kyoritsu

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment